Zoetis Inc. Net Income
Zoetis Inc. (ZTS) reported Net Income of $691.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-06
- Zoetis Inc. net income (loss) attributable to parent for the quarter ending 2026-06-30 was $691.00M, a 4.82% decline year-over-year.
- Zoetis Inc. net income (loss) attributable to parent for the quarter ending 2026-03-31 was $601.00M, a 0.17% decline year-over-year.
- Zoetis Inc. net income (loss) attributable to parent for the quarter ending 2025-12-31 was $603.00M, a 3.79% increase year-over-year.
- Zoetis Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was $721.00M, a 5.72% increase year-over-year.
- Zoetis Inc. net income (loss) attributable to parent for fiscal 2020 was $1.64B, a 9.20% increase from fiscal 2019.
- Zoetis Inc. net income (loss) attributable to parent for fiscal 2019 was $1.50B, a 5.04% increase from fiscal 2018.
- Zoetis Inc. net income (loss) attributable to parent for fiscal 2018 was $1.43B, a 65.28% increase from fiscal 2017.
- Zoetis Inc. net income (loss) attributable to parent for fiscal 2017 was $864.00M, a 5.24% increase from fiscal 2016.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $691.00M 10-Q · filed 2026-08-06 | $1.29B 10-Q · filed 2026-08-06 | $1.90B derived: sum of 3 quarters · filed 2026-08-06 | $2.62B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $601.00M 10-Q · filed 2026-05-07 | $1.20B derived: sum of 2 quarters · filed 2026-05-07 | $1.93B derived: sum of 3 quarters · filed 2026-05-07 | $2.65B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $603.00M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-08 | $1.32B derived: sum of 2 quarters · filed 2026-04-08 | $2.05B derived: sum of 3 quarters · filed 2026-08-06 | $2.67B DEF 14A · filed 2026-04-08 | ||
| 2025-09-30 | $721.00M 10-Q · filed 2025-11-04 | $1.45B derived: sum of 2 quarters · filed 2026-08-06 | $2.07B 10-Q · filed 2025-11-04 | $2.63B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $726.00M 10-Q · filed 2026-08-06 | $718.00M 10-Q · filed 2025-08-05 | $1.33B 10-Q · filed 2026-08-06 | $1.35B 10-Q · filed 2025-08-05 | $1.91B derived: sum of 3 quarters · filed 2026-08-06 | $2.59B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $602.00M 10-Q · filed 2026-05-07 | $631.00M 10-Q · filed 2025-05-06 | $1.18B derived: sum of 2 quarters · filed 2026-05-07 | $1.86B derived: sum of 3 quarters · filed 2026-05-07 | $2.49B derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $581.00M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-08 | $1.26B derived: sum of 2 quarters · filed 2026-04-08 | $1.89B derived: sum of 3 quarters · filed 2026-04-08 | $2.49B DEF 14A · filed 2026-04-08 | ||
| 2024-09-30 | $682.00M 10-Q · filed 2025-11-04 | $1.31B derived: sum of 2 quarters · filed 2025-11-04 | $1.91B 10-Q · filed 2025-11-04 | $2.43B derived: sum of 4 quarters · filed 2026-04-08 | ||
| 2024-06-30 | $624.00M 10-Q · filed 2025-08-05 | $1.22B 10-Q · filed 2025-08-05 | $1.75B derived: sum of 3 quarters · filed 2026-04-08 | $2.34B derived: sum of 4 quarters · filed 2026-04-08 | ||
| 2024-03-31 | $599.00M 10-Q · filed 2025-05-06 | $1.12B derived: sum of 2 quarters · filed 2026-04-08 | $1.72B derived: sum of 3 quarters · filed 2026-04-08 | $2.39B derived: sum of 4 quarters · filed 2026-04-08 | ||
| 2023-12-31 | $525.00M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-08 | $1.12B derived: sum of 2 quarters · filed 2026-04-08 | $1.79B derived: sum of 3 quarters · filed 2026-04-08 | $2.34B DEF 14A · filed 2026-04-08 | ||
| 2023-09-30 | $596.00M 10-Q · filed 2024-11-04 | $1.27B derived: sum of 2 quarters · filed 2024-11-04 | $1.82B 10-Q · filed 2024-11-04 | $2.28B derived: sum of 4 quarters · filed 2026-04-08 | ||
| 2023-06-30 | $671.00M 10-Q · filed 2024-08-06 | $1.22B 10-Q · filed 2024-08-06 | $1.68B derived: sum of 3 quarters · filed 2026-04-08 | $2.21B derived: sum of 4 quarters · filed 2026-04-08 | ||
| 2023-03-31 | $552.00M 10-Q · filed 2024-05-02 | $1.01B derived: sum of 2 quarters · filed 2026-04-08 | $1.54B derived: sum of 3 quarters · filed 2026-04-08 | $2.07B derived: sum of 4 quarters · filed 2026-04-08 | ||
| 2022-12-31 | $461.00M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-08 | $990.00M derived: sum of 2 quarters · filed 2026-04-08 | $1.52B derived: sum of 3 quarters · filed 2026-04-08 | $2.11B DEF 14A · filed 2026-04-08 | ||
| 2022-09-30 | $529.00M 10-Q · filed 2023-11-02 | $1.06B derived: sum of 2 quarters · filed 2023-11-02 | $1.65B 10-Q · filed 2023-11-02 | $2.07B derived: sum of 4 quarters · filed 2026-04-08 | ||
| 2022-06-30 | $529.00M 10-Q · filed 2023-08-08 | $1.12B 10-Q · filed 2023-08-08 | $1.54B derived: sum of 3 quarters · filed 2026-04-08 | $2.09B derived: sum of 4 quarters · filed 2026-04-08 | ||
| 2022-03-31 | $595.00M 10-Q · filed 2023-05-04 | $1.01B derived: sum of 2 quarters · filed 2026-04-08 | $1.56B derived: sum of 3 quarters · filed 2026-04-08 | $2.07B derived: sum of 4 quarters · filed 2026-04-08 | ||
| 2021-12-31 | $414.00M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-08 | $966.00M derived: sum of 2 quarters · filed 2026-04-08 | $1.48B derived: sum of 3 quarters · filed 2026-04-08 | $2.04B DEF 14A · filed 2026-04-08 | ||
| 2021-09-30 | $552.00M 10-Q · filed 2022-11-03 | $1.06B derived: sum of 2 quarters · filed 2022-11-03 | $1.62B 10-Q · filed 2022-11-03 | $1.98B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-06-30 | $512.00M 10-Q · filed 2022-08-04 | $1.07B 10-Q · filed 2022-08-04 | $1.43B derived: sum of 3 quarters · filed 2023-02-14 | $1.91B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-03-31 | $559.00M 10-Q · filed 2022-05-05 | $918.00M derived: sum of 2 quarters · filed 2023-02-14 | $1.40B derived: sum of 3 quarters · filed 2023-02-14 | $1.77B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2020-12-31 | $359.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $838.00M derived: sum of 2 quarters · filed 2023-02-14 | $1.22B derived: sum of 3 quarters · filed 2023-02-14 | $1.64B 10-K · filed 2023-02-14 | ||
| 2020-09-30 | $479.00M 10-Q · filed 2021-11-04 | $856.00M derived: sum of 2 quarters · filed 2021-11-04 | $1.28B 10-Q · filed 2021-11-04 | $1.66B derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $377.00M 10-Q · filed 2021-08-05 | $800.00M 10-Q · filed 2021-08-05 | $1.18B derived: sum of 3 quarters · filed 2021-08-05 | $1.62B derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $423.00M 10-Q · filed 2021-05-06 | $807.00M derived: sum of 2 quarters · filed 2021-05-06 | $1.24B derived: sum of 3 quarters · filed 2021-05-06 | $1.61B derived: sum of 4 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $384.00M 10-K · filed 2020-02-13 | $817.00M derived: sum of 2 quarters · filed 2020-11-05 | $1.19B derived: sum of 3 quarters · filed 2020-11-05 | $1.50B 10-K · filed 2022-02-15 | ||
| 2019-09-30 | $433.00M 10-Q · filed 2020-11-05 | $804.00M derived: sum of 2 quarters · filed 2020-11-05 | $1.12B 10-Q · filed 2020-11-05 | $1.46B derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $371.00M 10-Q · filed 2020-08-06 | $683.00M 10-Q · filed 2020-08-06 | $1.03B derived: sum of 3 quarters · filed 2020-08-06 | $1.38B derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $312.00M 10-Q · filed 2020-05-06 | $657.00M derived: sum of 2 quarters · filed 2020-05-06 | $1.00B derived: sum of 3 quarters · filed 2020-05-06 | $1.39B derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2018-12-31 | $345.00M 10-K · filed 2020-02-13 | $692.00M derived: sum of 2 quarters · filed 2020-02-13 | $1.08B derived: sum of 3 quarters · filed 2020-02-13 | $1.43B 10-K · filed 2021-02-16 | ||
| 2018-09-30 | $347.00M 10-K · filed 2020-02-13 | $731.00M derived: sum of 2 quarters · filed 2020-02-13 | $1.08B 10-Q · filed 2019-11-07 | $1.16B derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-06-30 | $384.00M 10-K · filed 2020-02-13 | $736.00M 10-Q · filed 2019-08-06 | $817.00M derived: sum of 3 quarters · filed 2020-02-13 | $1.11B derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-03-31 | $352.00M 10-K · filed 2020-02-13 | $433.00M derived: sum of 2 quarters · filed 2020-02-13 | $731.00M derived: sum of 3 quarters · filed 2020-02-13 | $978.00M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2017-12-31 | $81.00M 10-K · filed 2019-02-14 | $379.00M derived: sum of 2 quarters · filed 2019-02-14 | $626.00M derived: sum of 3 quarters · filed 2019-02-14 | $864.00M 10-K · filed 2020-02-13 | ||
| 2017-10-01 | $298.00M 10-K · filed 2019-02-14 | $545.00M derived: sum of 2 quarters · filed 2019-02-14 | $783.00M 10-Q · filed 2018-11-01 | $937.00M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-07-02 | $247.00M 10-K · filed 2019-02-14 | $485.00M 10-Q · filed 2018-08-02 | $639.00M derived: sum of 3 quarters · filed 2019-02-14 | $878.00M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-04-02 | $238.00M 10-K · filed 2019-02-14 | $392.00M derived: sum of 2 quarters · filed 2019-02-14 | $631.00M derived: sum of 3 quarters · filed 2019-02-14 | $855.00M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2016-12-31 | $154.00M 10-K · filed 2018-02-15 | $393.00M derived: sum of 2 quarters · filed 2018-02-15 | $617.00M derived: sum of 3 quarters · filed 2018-02-15 | $821.00M 10-K · filed 2019-02-14 | ||
| 2016-10-02 | $239.00M 10-K · filed 2018-02-15 | $463.00M derived: sum of 2 quarters · filed 2018-02-15 | $667.00M 10-Q · filed 2017-11-02 | $689.00M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2016-07-03 | $224.00M 10-K · filed 2018-02-15 | $428.00M 10-Q · filed 2017-08-08 | $450.00M derived: sum of 3 quarters · filed 2018-02-15 | $639.00M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2016-04-03 | $204.00M 10-K · filed 2018-02-15 | $226.00M derived: sum of 2 quarters · filed 2018-02-15 | $415.00M derived: sum of 3 quarters · filed 2018-02-15 | $378.00M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2015-12-31 | $22.00M 10-K · filed 2017-02-16 | $211.00M derived: sum of 2 quarters · filed 2017-02-16 | $174.00M derived: sum of 3 quarters · filed 2017-02-16 | $339.00M 10-K · filed 2018-02-15 | ||
| 2015-09-27 | $189.00M 10-K · filed 2017-02-16 | $152.00M derived: sum of 2 quarters · filed 2017-02-16 | $317.00M 10-Q · filed 2016-11-03 | $443.00M derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2015-06-28 | -$37.00M 10-K · filed 2017-02-16 | $128.00M 10-Q · filed 2016-08-05 | $254.00M derived: sum of 3 quarters · filed 2017-02-16 | $420.00M derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2015-03-29 | $165.00M 10-K · filed 2017-02-16 | $291.00M derived: sum of 2 quarters · filed 2017-02-16 | $457.00M derived: sum of 3 quarters · filed 2017-02-16 | $593.00M derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2014-12-31 | $126.00M 10-K · filed 2016-02-24 | $292.00M derived: sum of 2 quarters · filed 2016-02-24 | $428.00M derived: sum of 3 quarters · filed 2016-02-24 | $583.00M 10-K · filed 2017-02-16 | ||
| 2014-09-28 | $166.00M 10-K · filed 2016-02-24 | $302.00M derived: sum of 2 quarters · filed 2016-02-24 | $457.00M 10-Q · filed 2015-11-05 | $562.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-29 | $136.00M 10-K · filed 2016-02-24 | $291.00M 10-Q · filed 2015-08-06 | $396.00M derived: sum of 3 quarters · filed 2016-02-24 | $527.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-30 | $155.00M 10-K · filed 2016-02-24 | $260.00M derived: sum of 2 quarters · filed 2016-02-24 | $391.00M derived: sum of 3 quarters · filed 2016-02-24 | $519.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2013-12-31 | $105.00M 10-K · filed 2015-02-27 | $236.00M derived: sum of 2 quarters · filed 2015-02-27 | $364.00M derived: sum of 3 quarters · filed 2015-02-27 | $504.00M 10-K · filed 2016-02-24 | ||
| 2013-09-29 | $131.00M 10-K · filed 2015-02-27 | $259.00M derived: sum of 2 quarters · filed 2015-02-27 | $399.00M 10-Q · filed 2014-11-10 | $389.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $128.00M 10-K · filed 2015-02-27 | $268.00M 10-Q · filed 2014-08-12 | $258.00M derived: sum of 3 quarters · filed 2015-02-27 | $420.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $140.00M 10-K · filed 2015-02-27 | $130.00M derived: sum of 2 quarters · filed 2015-02-27 | $292.00M derived: sum of 3 quarters · filed 2015-02-27 | $465.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2012-12-31 | -$10.00M 10-K · filed 2014-03-26 | $152.00M derived: sum of 2 quarters · filed 2014-03-26 | $325.00M derived: sum of 3 quarters · filed 2014-03-26 | $436.00M 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $162.00M 10-K · filed 2014-03-26 | $335.00M derived: sum of 2 quarters · filed 2014-03-26 | $446.00M 10-Q · filed 2013-11-13 | |||
| 2012-07-01 | $173.00M 10-K · filed 2014-03-26 | $284.00M 10-Q · filed 2013-08-14 | ||||
| 2012-04-01 | $111.00M 10-K · filed 2014-03-26 | |||||
| 2011-12-31 | $245.00M 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |